{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T07:21:20Z","timestamp":1787469680801,"version":"build-2736575974"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04544-w","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T14:09:30Z","timestamp":1787407770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Melatonin in lung cancer: integrating molecular mechanisms, tumor microenvironment regulation, apoptotic signaling, and therapeutic opportunities"],"prefix":"10.1007","author":[{"given":"Jun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FangYuan","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0373-291X","authenticated-orcid":false,"given":"Sima-sadat","family":"Sabihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"4544_CR1","first-page":"87","volume":"65","author":"LA Torre","year":"2012","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2012;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"4544_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1807704","volume":"16","author":"L Ruge","year":"2026","unstructured":"Ruge L, Verheyen M, John F, Wolf J. Global disparities in access to diagnostics and therapies for advanced non-small cell lung cancer: from discovery to delivery - a review. Front Oncol. 2026;16:1807704.","journal-title":"Front Oncol"},{"key":"4544_CR3","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/ijc.70318","volume":"158","author":"M Mayuri","year":"2026","unstructured":"Mayuri M, Reddy Kandula S, Ramakrishna V, Sanka P, Sidde GP, Muzzamil SM, et al. Cutting edge therapies: a review of Food and Drug Administration-approved drugs for non-small cell lung cancer. Int J Cancer. 2026;158:2512\u20139.","journal-title":"Int J Cancer"},{"key":"4544_CR4","volume":"17","author":"A Bin Sumaida","year":"2025","unstructured":"Bin Sumaida A, Shanbhag NM, Pervez N, AlKaabi K, Balaraj K. Surgery versus stereotactic body radiotherapy for early-stage non-small cell lung cancer (NSCLC): a comprehensive review of survival and local control outcomes. Cureus. 2025;17:e84440.","journal-title":"Cureus"},{"key":"4544_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/cpr.12158","volume":"48","author":"P Plaimee","year":"2015","unstructured":"Plaimee P, Weerapreeyakul N, Barusrux S, Johns NP. Melatonin potentiates cisplatin-induced apoptosis and cell cycle arrest in human lung adenocarcinoma cells. Cell Prolif. 2015;48:67\u201377.","journal-title":"Cell Prolif"},{"key":"4544_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/cpr.12119","volume":"47","author":"P Plaimee","year":"2014","unstructured":"Plaimee P, Khamphio M, Weerapreeyakul N, Barusrux S, Johns NP. Immunomodulatory effect of melatonin in SK-LU-1 human lung adenocarcinoma cells co-cultured with peripheral blood mononuclear cells. Cell Prolif. 2014;47:406\u201315.","journal-title":"Cell Prolif"},{"issue":"2","key":"4544_CR7","doi-asserted-by":"publisher","first-page":"dju403","DOI":"10.1093\/jnci\/dju403","volume":"107","author":"BS Lee","year":"2015","unstructured":"Lee BS, Cho YW, Kim GC, Lee DH, Kim CJ, Kil HS, et al. Induced phenotype targeted therapy: radiation-induced apoptosis-targeted chemotherapy. J Natl Cancer Inst. 2015;107(2):dju403.","journal-title":"J Natl Cancer Inst"},{"key":"4544_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.biomaterials.2016.05.056","volume":"101","author":"NU Khaliq","year":"2016","unstructured":"Khaliq NU, Sandra FC, Park DY, Lee JY, Oh KS, Kim D, et al. Doxorubicin\/heparin composite nanoparticles for caspase-activated prodrug chemotherapy. Biomaterials. 2016;101:131\u201342.","journal-title":"Biomaterials"},{"key":"4544_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00866-3","volume":"29","author":"A Tiwari","year":"2022","unstructured":"Tiwari A, Trivedi R, Lin SY. Tumor microenvironment: barrier or opportunity towards effective cancer therapy. J Biomed Sci. 2022;29:83.","journal-title":"J Biomed Sci"},{"key":"4544_CR10","doi-asserted-by":"publisher","first-page":"57077","DOI":"10.18632\/oncotarget.10976","volume":"7","author":"E Panza","year":"2016","unstructured":"Panza E, De Cicco P, Ercolano G, Armogida C, Scognamiglio G, Anniciello AM, et al. Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival. Oncotarget. 2016;7:57077\u201385.","journal-title":"Oncotarget"},{"key":"4544_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/CMR.0000000000000549","volume":"29","author":"WJ Lee","year":"2019","unstructured":"Lee WJ, Lee MH, Kim HT, Won CH, Lee MW, Choi JH, et al. Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma. Melanoma Res. 2019;29:501\u20139.","journal-title":"Melanoma Res"},{"key":"4544_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s10495-008-0300-z","volume":"14","author":"A Frenzel","year":"2009","unstructured":"Frenzel A, Grespi F, Chmelewskij W, Villunger A. Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis. 2009;14:584\u201396.","journal-title":"Apoptosis"},{"key":"4544_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1158\/2159-8290.CD-15-0011","volume":"5","author":"AN Hata","year":"2015","unstructured":"Hata AN, Engelman JA, Faber AC. The BCL2 family: key mediators of the apoptotic response to targeted anticancer therapeutics. Cancer Discov. 2015;5:475\u201387.","journal-title":"Cancer Discov"},{"key":"4544_CR14","first-page":"2003","volume":"18","author":"T Inada","year":"1998","unstructured":"Inada T, Kikuyama S, Ichikawa A, Igarashi S, Ogata Y. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma. Anticancer Res. 1998;18:2003\u201310.","journal-title":"Anticancer Res"},{"key":"4544_CR15","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1038\/sj.onc.1204535","volume":"20","author":"S Huang","year":"2001","unstructured":"Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncog. 2001;20:4188\u201397.","journal-title":"Oncog"},{"key":"4544_CR16","first-page":"2104","volume":"6","author":"K Inoue","year":"2000","unstructured":"Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, et al. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res. 2000;6:2104\u201319.","journal-title":"Clin Cancer Res"},{"key":"4544_CR17","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.32604\/biocell.2025.067661","volume":"49","author":"RJ Reiter","year":"2025","unstructured":"Reiter RJ, Sharma R, Manucha W, Balduini W, Loh D, Spandidos DA, et al. Mechanistic insights into the role of melatonin in cancer cell chemoresistance. Biocell. 2025;49:2033\u201367.","journal-title":"Biocell"},{"key":"4544_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27104496","author":"RJ Reiter","year":"2026","unstructured":"Reiter RJ, Sharma R, Loh D, Chuffa LGA, Bai Y, Zuccari D, et al. Melatonin targets mitochondrial redox homeostasis: optimizing the intracellular microenvironment. Int J Mol Sci. 2026. https:\/\/doi.org\/10.3390\/ijms27104496.","journal-title":"Int J Mol Sci"},{"key":"4544_CR19","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1080\/10408398.2018.1487927","volume":"59","author":"SM Nabavi","year":"2019","unstructured":"Nabavi SM, Nabavi SF, Sureda A, Xiao J, Dehpour AR, Shirooie S, et al. Anti-inflammatory effects of melatonin: a mechanistic review. Crit Rev Food Sci Nutr. 2019;59:S4-s16.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4544_CR20","first-page":"5449","volume":"37","author":"R Bakalova","year":"2017","unstructured":"Bakalova R, Zhelev Z, Shibata S, Nikolova B, Aoki I, Higashi T. Impressive suppression of colon cancer growth by triple combination SN38\/EF24\/Melatonin: \u201cOncogenic\u201d versus \u201cOnco-Suppressive\u201d reactive oxygen species. Anticancer Res. 2017;37:5449\u201358.","journal-title":"Anticancer Res"},{"key":"4544_CR21","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00280-016-3172-x","volume":"78","author":"G He","year":"2016","unstructured":"He G, Feng C, Vinothkumar R, Chen W, Dai X, Chen X, et al. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells. Cancer Chemother Pharmacol. 2016;78:1151\u201361.","journal-title":"Cancer Chemother Pharmacol"},{"key":"4544_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s004320050010","volume":"126","author":"G Srinivas","year":"2000","unstructured":"Srinivas G, Kusumakumary P, Nair MK, Panicker KR, Pillai MR. Mutant p53 protein, Bcl-2\/Bax ratios and apoptosis in paediatric acute lymphoblastic leukaemia. J Cancer Res Clin Oncol. 2000;126:62\u20137.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4544_CR23","first-page":"5754","volume":"60","author":"B Gong","year":"2000","unstructured":"Gong B, Almasan A. Apo2 ligand\/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells. Cancer Res. 2000;60:5754\u201360.","journal-title":"Cancer Res"},{"key":"4544_CR24","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1038\/sj.onc.1207830","volume":"23","author":"S Nakata","year":"2004","unstructured":"Nakata S, Yoshida T, Horinaka M, Shiraishi T, Wakada M, Sakai T. Histone deacetylase inhibitors upregulate death receptor 5\/TRAIL-R2 and sensitize apoptosis induced by TRAIL\/APO2-L in human malignant tumor cells. Oncogene. 2004;23:6261\u201371.","journal-title":"Oncogene"},{"key":"4544_CR25","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021;18:1106\u201321.","journal-title":"Cell Mol Immunol"},{"key":"4544_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/07357907.2024.2445528","volume":"43","author":"M Mosadegh","year":"2025","unstructured":"Mosadegh M, Noori Goodarzi N, Erfani Y. A comprehensive insight into apoptosis: molecular mechanisms, signaling pathways, and modulating therapeutics. Cancer Invest. 2025;43:33\u201358.","journal-title":"Cancer Invest"},{"key":"4544_CR27","volume-title":"Biochemistry, extrinsic pathway of apoptosis","author":"A Yanumula","year":"2020","unstructured":"Yanumula A, Cusick JK. Biochemistry, extrinsic pathway of apoptosis. FL: StatPearls Publishing; 2020."},{"key":"4544_CR28","first-page":"99","volume-title":"Methods in enzymology","author":"P Nair","year":"2014","unstructured":"Nair P, Lu M, Petersen S, Ashkenazi A. Apoptosis initiation through the cell-extrinsic pathway. In: Methods in enzymology. Elsevier; 2014. p. 99\u2013128."},{"key":"4544_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/616149","volume":"2014","author":"C Loreto","year":"2014","unstructured":"Loreto C, La Rocca G, Anzalone R, Caltabiano R, Vespasiani G, Castorina S, et al. The role of intrinsic pathway in apoptosis activation and progression in Peyronie\u2019s disease. Biomed Res Int. 2014;2014:616149.","journal-title":"Biomed Res Int"},{"key":"4544_CR30","volume-title":"Apoptosis and medicine","author":"Z Hongmei","year":"2012","unstructured":"Hongmei Z. Extrinsic and intrinsic apoptosis signal pathway review. In: Apoptosis and medicine. InTechOpen; 2012."},{"key":"4544_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12935-019-0853-7","volume":"19","author":"MH Pourhanifeh","year":"2019","unstructured":"Pourhanifeh MH, Sharifi M, Reiter RJ, Davoodabadi A, Asemi Z. Melatonin and non-small cell lung cancer: new insights into signaling pathways. Cancer Cell Int. 2019;19:131.","journal-title":"Cancer Cell Int"},{"key":"4544_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","volume":"10","author":"M Vogler","year":"2025","unstructured":"Vogler M, Braun Y, Smith VM, Westhoff MA, Pereira RS, Pieper NM, et al. The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy. Signal Transduct Target Ther. 2025;10:91.","journal-title":"Signal Transduct Target Ther"},{"key":"4544_CR33","doi-asserted-by":"publisher","first-page":"1617508","DOI":"10.3389\/fphar.2025.1617508","volume":"16","author":"Y Cao","year":"2025","unstructured":"Cao Y, Zhang H, Chen X, Li C, Chen J. Melatonin: a natural guardian in cancer treatment. Front Pharmacol. 2025;16:1617508.","journal-title":"Front Pharmacol"},{"key":"4544_CR34","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1080\/07420528.2021.1963759","volume":"38","author":"N Nagariya","year":"2021","unstructured":"Nagariya N, Chaudhari K, Vasu VT. Circadian disruption in lung cancer. Chronobiol Int. 2021;38:1797\u2013808.","journal-title":"Chronobiol Int"},{"key":"4544_CR35","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.febslet.2010.03.017","volume":"584","author":"A Sancar","year":"2010","unstructured":"Sancar A, Lindsey-Boltz LA, Kang TH, Reardon JT, Lee JH, Ozturk N. Circadian clock control of the cellular response to DNA damage. FEBS Lett. 2010;584:2618\u201325.","journal-title":"FEBS Lett"},{"key":"4544_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1021\/bi5007354","volume":"54","author":"A Sancar","year":"2015","unstructured":"Sancar A, Lindsey-Boltz LA, Gaddameedhi S, Selby CP, Ye R, Chiou YY, et al. Circadian clock, cancer, and chemotherapy. Biochem. 2015;54:110\u201323.","journal-title":"Biochem"},{"key":"4544_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.molcel.2006.03.038","volume":"22","author":"S Gery","year":"2006","unstructured":"Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell. 2006;22:375\u201382.","journal-title":"Mol Cell"},{"key":"4544_CR38","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cmet.2016.07.001","volume":"24","author":"T Papagiannakopoulos","year":"2016","unstructured":"Papagiannakopoulos T, Bauer MR, Davidson SM, Heimann M, Subbaraj L, Bhutkar A, et al. Circadian rhythm disruption promotes lung tumorigenesis. Cell Metab. 2016;24:324\u201331.","journal-title":"Cell Metab"},{"issue":"22","key":"4544_CR39","doi-asserted-by":"publisher","first-page":"13722","DOI":"10.3390\/ijms232213722","volume":"23","author":"V Jerigova","year":"2022","unstructured":"Jerigova V, Zeman M, Okuliarova M. Circadian disruption and consequences on innate immunity and inflammatory response. Int J Mol Sci. 2022;23(22):13722.","journal-title":"Int J Mol Sci"},{"key":"4544_CR40","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302261RR","volume":"38","author":"Z Yang","year":"2024","unstructured":"Yang Z, Black K, Ohman-Strickland P, Graber JM, Kipen HM, Fang M, et al. Disruption of central and peripheral circadian clocks and circadian controlled estrogen receptor rhythms in night shift nurses in working environments. Faseb J. 2024;38:e23719.","journal-title":"Faseb J"},{"key":"4544_CR41","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.lfs.2019.05.009","volume":"228","author":"K Mortezaee","year":"2019","unstructured":"Mortezaee K, Najafi M, Farhood B, Ahmadi A, Potes Y, Shabeeb D, et al. Modulation of apoptosis by melatonin for improving cancer treatment efficiency: an updated review. Life Sci. 2019;228:228\u201341.","journal-title":"Life Sci"},{"key":"4544_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/1874467211666180830150154","volume":"11","author":"S Abadi","year":"2018","unstructured":"Abadi S, Shirazi A, Alizadeh AM, Changizi V, Najafi M, Khalighfard S, et al. The effect of melatonin on superoxide dismutase and glutathione peroxidase activity, and malondialdehyde levels in the targeted and the non-targeted lung and heart tissues after irradiation in xenograft mice colon cancer. Curr Mol Pharmacol. 2018;11:326\u201335.","journal-title":"Curr Mol Pharmacol"},{"key":"4544_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4103\/jmp.JMP_60_17","volume":"42","author":"A Ghobadi","year":"2017","unstructured":"Ghobadi A, Shirazi A, Najafi M, Kahkesh MH, Rezapoor S. Melatonin ameliorates radiation-induced oxidative stress at targeted and nontargeted lung tissue. J Med Phys. 2017;42:241\u20134.","journal-title":"J Med Phys"},{"key":"4544_CR44","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12461","volume":"64","author":"YQ Shen","year":"2018","unstructured":"Shen YQ, Guerra\u2010Librero A, Fernandez\u2010Gil BI, Florido J, Garc\u00eda\u2010L\u00f3pez S, Martinez\u2010Ruiz L, et al. Combination of melatonin and rapamycin for head and neck cancer therapy: suppression of AKT\/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation. J Pineal Res. 2018;64:e12461.","journal-title":"J Pineal Res"},{"key":"4544_CR45","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3892\/or.2015.3738","volume":"33","author":"U Laothong","year":"2015","unstructured":"Laothong U, Hiraku Y, Oikawa S, Intuyod K, Murata M, Pinlaor S. Melatonin induces apoptosis in cholangiocarcinoma cell lines by activating the reactive oxygen species-mediated mitochondrial pathway. Oncol Rep. 2015;33:1443\u20139.","journal-title":"Oncol Rep"},{"key":"4544_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00791","volume":"10","author":"L Liu","year":"2019","unstructured":"Liu L, Labani N, Cecon E, Jockers R. Melatonin target proteins: too many or not enough? Front Endocrinol. 2019;10:791.","journal-title":"Front Endocrinol"},{"key":"4544_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11071001","volume":"11","author":"K Jablonska","year":"2019","unstructured":"Jablonska K, Nowinska K, Piotrowska A, Partynska A, Katnik E, Pawelczyk K, et al. Prognostic impact of melatonin receptors MT1 and MT2 in non-small cell lung cancer (NSCLC). Cancers. 2019;11:1001.","journal-title":"Cancers"},{"key":"4544_CR48","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1042\/CS20180945","volume":"133","author":"C-C Chao","year":"2019","unstructured":"Chao C-C, Chen P-C, Chiou P-C, Hsu C-J, Liu P-I, Yang Y-C, et al. Melatonin suppresses lung cancer metastasis by inhibition of epithelial\u2013mesenchymal transition through targeting to Twist. Clin Sci. 2019;133:709\u201322.","journal-title":"Clin Sci"},{"key":"4544_CR49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00408-023-00610-0","volume":"201","author":"F He","year":"2023","unstructured":"He F, Wang Q-F, Li L, Yu C, Liu C-Z, Wei W-C, et al. Melatonin protects against hyperoxia-induced apoptosis in alveolar epithelial type II cells by activating the MT2\/PI3K\/AKT\/ETS1 signaling pathway. Lung. 2023;201:225\u201334.","journal-title":"Lung"},{"key":"4544_CR50","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"4544_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.720025","volume":"12","author":"H Abolhassani","year":"2021","unstructured":"Abolhassani H, Wang Y, Hammarstr\u00f6m L, Pan-Hammarstr\u00f6m Q. Hallmarks of cancers: primary antibody deficiency versus other inborn errors of immunity. Front Immunol. 2021;12:720025.","journal-title":"Front Immunol"},{"key":"4544_CR52","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12029-013-9552-0","volume":"45","author":"NN Nasrabadi","year":"2014","unstructured":"Nasrabadi NN, Ataee R, Abediankenari S, Shokrzadeh M, Najafi M, Hoseini SV, et al. Expression of MT2 receptor in patients with gastric adenocarcinoma and its relationship with clinicopathological features. J Gastrointest Cancer. 2014;45:54\u201360.","journal-title":"J Gastrointest Cancer"},{"key":"4544_CR53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1042\/BST0370605","volume":"37","author":"I Stoimenov","year":"2009","unstructured":"Stoimenov I, Helleday T. PCNA on the crossroad of cancer. Biochem Soc Trans. 2009;37:605\u201313.","journal-title":"Biochem Soc Trans"},{"key":"4544_CR54","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1021\/bi400194r","volume":"52","author":"K Yang","year":"2013","unstructured":"Yang K, Weinacht CP, Zhuang Z. Regulatory role of ubiquitin in eukaryotic DNA translesion synthesis. Biochemistry. 2013;52:3217\u201328.","journal-title":"Biochemistry"},{"key":"4544_CR55","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/cpr.12140","volume":"47","author":"P Plaimee","year":"2014","unstructured":"Plaimee P, Weerapreeyakul N, Thumanu K, Tanthanuch W, Barusrux S. Melatonin induces apoptosis through biomolecular changes, in SK-LU-1 human lung adenocarcinoma cells. Cell Prolif. 2014;47:564\u201377.","journal-title":"Cell Prolif"},{"key":"4544_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101132","volume":"9","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Gui S, Zhou Q, Wang Y. Melatonin inhibits the migration of human lung adenocarcinoma A549 cell lines involving JNK\/MAPK pathway. PLoS ONE. 2014;9:e101132.","journal-title":"PLoS ONE"},{"key":"4544_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/tox.22674","volume":"34","author":"YC Yang","year":"2019","unstructured":"Yang YC, Chiou PC, Chen PC, Liu PY, Huang WC, Chao CC, et al. Melatonin reduces lung cancer stemness through inhibiting of PLC, ERK, p38, \u03b2\u2010catenin, and Twist pathways. Environ Toxicol. 2019;34:203\u20139.","journal-title":"Environ Toxicol"},{"key":"4544_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jpi.12270","volume":"60","author":"TF Borin","year":"2016","unstructured":"Borin TF, Arbab AS, Gelaleti GB, Ferreira LC, Moschetta MG, Jardim\u2010Perassi BV, et al. Melatonin decreases breast cancer metastasis by modulating Rho\u2010associated kinase protein\u20101 expression. J Pineal Res. 2016;60:3\u201315.","journal-title":"J Pineal Res"},{"key":"4544_CR59","first-page":"4383","volume":"58","author":"S Cos","year":"1998","unstructured":"Cos S, Fern\u00e1ndez R, G\u00fc\u00e9zmes A, S\u00e1nchez-Barcel\u00f3 EJ. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Can Res. 1998;58:4383\u201390.","journal-title":"Can Res"},{"key":"4544_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02618-z","volume":"18","author":"I Hwang","year":"2020","unstructured":"Hwang I, Kim JW, Ylaya K, Chung EJ, Kitano H, Perry C, et al. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients. J Transl Med. 2020;18:443.","journal-title":"J Transl Med"},{"key":"4544_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01709-5","volume":"39","author":"X Jiang","year":"2020","unstructured":"Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z, et al. The role of microenvironment in tumor angiogenesis. J Exp Clin Cancer Res. 2020;39:204.","journal-title":"J Exp Clin Cancer Res"},{"key":"4544_CR62","doi-asserted-by":"publisher","first-page":"12225","DOI":"10.18632\/aging.206057","volume":"16","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Ma D, Qin Y, Xu Y, Li S, Liu H. Melatonin downregulates angiogenesis and lymphangiogenesis by regulating tumor-associated macrophages via NLRP3 inflammasomes in lung adenocarcinoma. Aging (Albany NY). 2024;16:12225\u201338.","journal-title":"Aging (Albany NY)"},{"key":"4544_CR63","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4087298","author":"X Wu","year":"2019","unstructured":"Wu X, Ji H, Wang Y, Gu C, Gu W, Hu L, et al. Melatonin alleviates radiation\u2010induced lung injury via regulation of miR\u201030e\/NLRP3 axis. Oxid Med Cell Longev. 2019. https:\/\/doi.org\/10.1155\/2019\/4087298.","journal-title":"Oxid Med Cell Longev"},{"key":"4544_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115649","volume":"22","author":"Y-C Chao","year":"2021","unstructured":"Chao Y-C, Lee K-Y, Wu S-M, Kuo D-Y, Shueng P-W, Lin C-W. Melatonin downregulates PD-L1 expression and modulates tumor immunity in KRAS-mutant non-small cell lung cancer. Int J Mol Sci. 2021;22:5649.","journal-title":"Int J Mol Sci"},{"key":"4544_CR65","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/0277-5379(89)90122-3","volume":"25","author":"P Lissoni","year":"1989","unstructured":"Lissoni P, Barni S, Crispino S, Tancini G, Fraschini F. Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur J Cancer Clin Oncol. 1989;25:789\u201395.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"4544_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00745-7","volume":"6","author":"M Li","year":"2021","unstructured":"Li M, Hao B, Zhang M, Reiter RJ, Lin S, Zheng T, et al. Melatonin enhances radiofrequency-induced NK antitumor immunity, causing cancer metabolism reprogramming and inhibition of multiple pulmonary tumor development. Signal Transduct Target Ther. 2021;6:330.","journal-title":"Signal Transduct Target Ther"},{"key":"4544_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12755","volume":"71","author":"X Chen","year":"2021","unstructured":"Chen X, Hao B, Li D, Reiter RJ, Bai Y, Abay B, et al. Melatonin inhibits lung cancer development by reversing the Warburg effect via stimulating the SIRT3\/PDH axis. J Pineal Res. 2021;71:e12755.","journal-title":"J Pineal Res"},{"key":"4544_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.110900","volume":"391","author":"JW Lee","year":"2024","unstructured":"Lee JW, Lee H, Noh S-W, Choi H-K. Co-treatment with melatonin and ortho-topolin riboside reduces cell viability by altering metabolic profiles in non-small cell lung cancer cells. Chem Biol Interact. 2024;391:110900.","journal-title":"Chem Biol Interact"},{"key":"4544_CR69","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1600-079X.2012.01003.x","volume":"53","author":"N Song","year":"2012","unstructured":"Song N, Kim AJ, Kim HJ, Jee HJ, Kim M, Yoo YH, et al. Melatonin suppresses doxorubicin\u2010induced premature senescence of A549 lung cancer cells by ameliorating mitochondrial dysfunction. J Pineal Res. 2012;53:335\u201343.","journal-title":"J Pineal Res"},{"key":"4544_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100763","author":"D Seely","year":"2021","unstructured":"Seely D, Legacy M, Auer RC, Fazekas A, Delic E, Anstee C, et al. Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): a randomized placebo controlled clinical trial. EClinicalMedicine. 2021. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100763.","journal-title":"EClinicalMedicine"},{"key":"4544_CR71","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1034\/j.1600-079X.2003.00032.x","volume":"35","author":"P Lissoni","year":"2003","unstructured":"Lissoni P, Chilelli M, Villa S, Cerizza L, Tancini G. Five years survival in metastatic non\u2010small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res. 2003;35:12\u20135.","journal-title":"J Pineal Res"},{"key":"4544_CR72","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/09291016.2021.1899485","volume":"53","author":"WJ Hrushesky","year":"2022","unstructured":"Hrushesky WJ, Lis CG, Levin RD, Grutsch JF, Birdsall T, Wood PA, et al. Daily evening melatonin prolongs survival among patients with advanced non-small-cell lung cancer. Biol Rhythm Res. 2022;53:1043\u201357.","journal-title":"Biol Rhythm Res"},{"key":"4544_CR73","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/10408363.2015.1092496","volume":"53","author":"K Meehan","year":"2016","unstructured":"Meehan K, Vella LJ. The contribution of tumour-derived exosomes to the hallmarks of cancer. Crit Rev Clin Lab Sci. 2016;53:121\u201331.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"4544_CR74","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/carcin\/21.3.485","volume":"21","author":"SW Lowe","year":"2000","unstructured":"Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000;21:485\u201395.","journal-title":"Carcinogenesis"},{"key":"4544_CR75","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1517\/14728222.2013.834890","volume":"17","author":"M Bizzarri","year":"2013","unstructured":"Bizzarri M, Proietti S, Cucina A, Reiter RJ. Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review. Expert Opin Ther Targets. 2013;17:1483\u201396.","journal-title":"Expert Opin Ther Targets"},{"key":"4544_CR76","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lfs.2014.08.024","volume":"115","author":"J Vriend","year":"2014","unstructured":"Vriend J, Reiter RJ. Melatonin as a proteasome inhibitor. Is there any clinical evidence? Life Sci. 2014;115:8\u201314.","journal-title":"Life Sci"},{"key":"4544_CR77","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1442-2042.2012.02967.x","volume":"19","author":"K Tsapakidis","year":"2012","unstructured":"Tsapakidis K, Vlachostergios PJ, Voutsadakis IA, Befani CD, Patrikidou A, Hatzidaki E, et al. Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cells. Int J Urol. 2012;19:565\u201374.","journal-title":"Int J Urol"},{"key":"4544_CR78","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/jpi.12150","volume":"57","author":"S Proietti","year":"2014","unstructured":"Proietti S, Cucina A, Dobrowolny G, D\u2019Anselmi F, Dinicola S, Masiello MG, et al. Melatonin down-regulates MDM2 gene expression and enhances p53 acetylation in MCF-7 cells. J Pineal Res. 2014;57:120\u20139.","journal-title":"J Pineal Res"},{"issue":"466","key":"4544_CR79","doi-asserted-by":"publisher","first-page":"eaai8026","DOI":"10.1126\/scisignal.aai8026","volume":"10","author":"NT Nihira","year":"2017","unstructured":"Nihira NT, Ogura K, Shimizu K, North BJ, Zhang J, Gao D, et al. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function. Sci Signal. 2017;10(466):eaai8026.","journal-title":"Sci Signal"},{"key":"4544_CR80","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/jpi.12119","volume":"56","author":"Y Hong","year":"2014","unstructured":"Hong Y, Won J, Lee Y, Lee S, Park K, Chang KT, et al. Melatonin treatment induces interplay of apoptosis, autophagy, and senescence in human colorectal cancer cells. J Pineal Res. 2014;56:264\u201374.","journal-title":"J Pineal Res"},{"key":"4544_CR81","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10495-015-1142-0","volume":"20","author":"S Di","year":"2015","unstructured":"Di S, Fan C, Yang Y, Jiang S, Liang M, Wu G, et al. Activation of endoplasmic reticulum stress is involved in the activity of icariin against human lung adenocarcinoma cells. Apoptosis. 2015;20:1229\u201341.","journal-title":"Apoptosis"},{"key":"4544_CR82","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/jpi.12288","volume":"60","author":"R Pariente","year":"2016","unstructured":"Pariente R, Pariente JA, Rodr\u00edguez AB, Espino J. Melatonin sensitizes human cervical cancer HeLa cells to cisplatin-induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentation. J Pineal Res. 2016;60:55\u201364.","journal-title":"J Pineal Res"},{"key":"4544_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11626-017-0200-z","volume":"54","author":"L Chen","year":"2018","unstructured":"Chen L, Liu L, Li Y, Gao J. Melatonin increases human cervical cancer HeLa cells apoptosis induced by cisplatin via inhibition of JNK\/Parkin\/mitophagy axis. In Vitro Cell Dev Biol Anim. 2018;54:1\u201310.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"4544_CR84","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1600-079X.1997.tb00329.x","volume":"23","author":"P Lissoni","year":"1997","unstructured":"Lissoni P, Paolorossi F, Ardizzoia A, Barni S, Chilelli M, Mancuso M, et al. A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state. J Pineal Res. 1997;23:15\u20139.","journal-title":"J Pineal Res"},{"key":"4544_CR85","first-page":"7327","volume":"34","author":"A Sookprasert","year":"2014","unstructured":"Sookprasert A, Johns NP, Phunmanee A, Pongthai P, Cheawchanwattana A, Johns J, et al. Melatonin in patients with cancer receiving chemotherapy: a randomized, double-blind, placebo-controlled trial. Anticancer Res. 2014;34:7327\u201337.","journal-title":"Anticancer Res"},{"key":"4544_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9040357","author":"S Gurunathan","year":"2020","unstructured":"Gurunathan S, Jeyaraj M, Kang MH, Kim JH. Melatonin enhances palladium-nanoparticle-induced cytotoxicity and apoptosis in human lung epithelial adenocarcinoma cells A549 and H1229. Antioxidants (Basel). 2020. https:\/\/doi.org\/10.3390\/antiox9040357.","journal-title":"Antioxidants (Basel)"},{"key":"4544_CR87","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1159\/000366305","volume":"34","author":"M Yun","year":"2014","unstructured":"Yun M, Kim EO, Lee D, Kim JH, Kim J, Lee H, et al. Melatonin sensitizes H1975 non-small-cell lung cancer cells harboring a T790M-targeted epidermal growth factor receptor mutation to the tyrosine kinase inhibitor gefitinib. Cell Physiol Biochem. 2014;34:865\u201372.","journal-title":"Cell Physiol Biochem"},{"key":"4544_CR88","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s12931-024-03042-3","volume":"25","author":"J Xiong","year":"2024","unstructured":"Xiong J, Xie L, Huang Y, Zhu J, Hong Z, Qian H, et al. Therapeutic effects of melatonin on the lungs of rats exposed to passive smoking. Respir Res. 2024;25:411.","journal-title":"Respir Res"},{"key":"4544_CR89","doi-asserted-by":"publisher","first-page":"10919","DOI":"10.1007\/s13277-014-2370-6","volume":"35","author":"W Kim","year":"2014","unstructured":"Kim W, Jeong JW, Kim JE. CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells. Tumour Biol. 2014;35:10919\u201329.","journal-title":"Tumour Biol"},{"key":"4544_CR90","first-page":"3462","volume":"13","author":"H Liu","year":"2022","unstructured":"Liu H, Wang F, Zhao J, Zhang X, Zeng Z, Wang S, et al. The effect and mechanisms of melatonin on the proliferation and apoptosis of lung cancer cells. Bioeng. 2022;13:3462\u20139.","journal-title":"Bioeng"},{"key":"4544_CR91","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12587","volume":"67","author":"Z Ma","year":"2019","unstructured":"Ma Z, Liu D, Di S, Zhang Z, Li W, Zhang J, et al. Histone deacetylase 9 downregulation decreases tumor growth and promotes apoptosis in non-small cell lung cancer after melatonin treatment. J Pineal Res. 2019;67:e12587.","journal-title":"J Pineal Res"},{"key":"4544_CR92","doi-asserted-by":"publisher","DOI":"10.1093\/rpsppr\/rqad034","volume":"2","author":"ME Elbanan","year":"2023","unstructured":"Elbanan ME, Amer ME, El-Missiry MA, Othman AI, Shabana SM. Melatonin protects mice from 5-FU hepatotoxicity and improves 5-FU antitumor effects by an apoptotic pathway dependent on cell cycle arrest in A549 human lung cancer cells. RPS Pharm Pharmacol Rep. 2023;2:rqad034.","journal-title":"RPS Pharm Pharmacol Rep"},{"key":"4544_CR93","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.18632\/oncotarget.6407","volume":"7","author":"JJ Lu","year":"2016","unstructured":"Lu JJ, Fu L, Tang Z, Zhang C, Qin L, Wang J, et al. Melatonin inhibits AP-2\u03b2\/hTERT, NF-\u03baB\/COX-2 and Akt\/ERK and activates caspase\/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells. Oncotarget. 2016;7:2985\u20133001.","journal-title":"Oncotarget"},{"key":"4544_CR94","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12813","volume":"73","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang Z, Shao C, Lu G, Xie M, Wang J, et al. Melatonin may suppress lung adenocarcinoma progression via regulation of the circular noncoding RNA hsa_circ_0017109\/miR-135b-3p\/TOX3 axis. J Pineal Res. 2022;73:e12813.","journal-title":"J Pineal Res"},{"key":"4544_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112680","author":"S Reda El Sayed","year":"2021","unstructured":"Reda El Sayed S, Cristante J, Guyon L, Denis J, Chabre O, Cherradi N. MicroRNA therapeutics in cancer: current advances and challenges. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13112680.","journal-title":"Cancers (Basel)"},{"key":"4544_CR96","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1038\/oncsis.2017.50","volume":"6","author":"YL Li","year":"2017","unstructured":"Li YL, Liu XM, Zhang CY, Zhou JB, Shao Y, Liang C, et al. MicroRNA-34a\/EGFR axis plays pivotal roles in lung tumorigenesis. Oncogenesis. 2017;6:e372.","journal-title":"Oncogenesis"},{"key":"4544_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067581","volume":"8","author":"M Garofalo","year":"2013","unstructured":"Garofalo M, Jeon Y-J, Nuovo GJ, Middleton J, Secchiero P, Joshi P, et al. MiR-34a\/c-dependent PDGFR-\u03b1\/\u03b2 downregulation inhibits tumorigenesis and enhances TRAIL-induced apoptosis in lung cancer. PLoS ONE. 2013;8:e67581.","journal-title":"PLoS ONE"},{"key":"4544_CR98","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s13277-014-2861-5","volume":"36","author":"Z-L Ma","year":"2015","unstructured":"Ma Z-L, Hou P-P, Li Y-L, Wang D-T, Yuan T-W, Wei J-L, et al. MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGF\u03b2R2. Tumour Biol. 2015;36:2481\u201390.","journal-title":"Tumour Biol"},{"key":"4544_CR99","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1261\/rna.052571.115","volume":"22","author":"C-Y Cho","year":"2016","unstructured":"Cho C-Y, Huang J-S, Shiah S-G, Chung S-Y, Lay J-D, Yang Y-Y, et al. Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells. RNA. 2016;22:303\u201315.","journal-title":"RNA"},{"key":"4544_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-020-1154-6","volume":"20","author":"S Huang","year":"2020","unstructured":"Huang S, Li C, Huang J, Luo P, Mo D, Wang H. LncRNA FEZF1-AS1 promotes non-small lung cancer cell migration and invasion through the up-regulation of NOTCH1 by serving as a sponge of miR-34a. BMC Pulm Med. 2020;20:1\u20137.","journal-title":"BMC Pulm Med"},{"key":"4544_CR101","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41598-017-00913-2","volume":"7","author":"J Ren","year":"2017","unstructured":"Ren J, Ding L, Xu Q, Shi G, Li X, Li X, et al. LF-MF inhibits iron metabolism and suppresses lung cancer through activation of P53-miR-34a-E2F1\/E2F3 pathway. Sci Rep. 2017;7:749.","journal-title":"Sci Rep"},{"key":"4544_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.619346","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Hou C, Zhao L-x, Cai Q-c, Zhang Y, Li D-l, et al. The association of microRNA-34a with high incidence and metastasis of lung cancer in Gejiu and Xuanwei Yunnan. Front Oncol. 2021;11:619346.","journal-title":"Front Oncol"},{"key":"4544_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090022","volume":"9","author":"Y Shi","year":"2014","unstructured":"Shi Y, Liu C, Liu X, Tang DG, Wang J. The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells. PLoS ONE. 2014;9:e90022.","journal-title":"PLoS ONE"},{"key":"4544_CR104","doi-asserted-by":"publisher","first-page":"13149","DOI":"10.18632\/oncotarget.3693","volume":"6","author":"Z Han","year":"2015","unstructured":"Han Z, Zhang Y, Yang Q, Liu B, Wu J, Zhang Y, et al. MiR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1). Oncotarget. 2015;6:13149.","journal-title":"Oncotarget"},{"key":"4544_CR105","first-page":"1135","volume":"11","author":"L Ruan","year":"2018","unstructured":"Ruan L, Chen J, Ruan L, Tan A, Wang P. miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6. Int J Clin Exp Pathol. 2018;11:1135.","journal-title":"Int J Clin Exp Pathol"},{"key":"4544_CR106","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.11826","author":"G Ji","year":"2021","unstructured":"Ji G, Zhou W, Li X, Du J, Li X, Hao H. Melatonin inhibits proliferation and viability and promotes apoptosis in colorectal cancer cells via upregulation of the microRNA-34a\/449a cluster. Mol Med Rep. 2021. https:\/\/doi.org\/10.3892\/mmr.2021.11826.","journal-title":"Mol Med Rep"},{"key":"4544_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091053","author":"A Stacchiotti","year":"2019","unstructured":"Stacchiotti A, Grossi I, Garc\u00eda-G\u00f3mez R, Patel GA, Salvi A, Lavazza A, et al. Melatonin effects on non-alcoholic fatty liver disease are related to microRNA-34a-5p\/Sirt1 axis and autophagy. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8091053.","journal-title":"Cells"},{"key":"4544_CR108","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.2741\/4788","volume":"24","author":"L Dai","year":"2019","unstructured":"Dai L, Chen F, Zheng Y, Zhang D, Qian B, Ji H, et al. miR-21 regulates growth and EMT in lung cancer cells via PTEN\/Akt\/GSK3\u03b2 signaling. Front Biosci (Landmark edition). 2019;24:1426\u201339.","journal-title":"Front Biosci (Landmark edition)"},{"key":"4544_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.950043","volume":"12","author":"J Bai","year":"2022","unstructured":"Bai J, Shi Z, Wang S, Pan H, Zhang T. MiR-21 and let-7 cooperation in the regulation of lung cancer. Front Oncol. 2022;12:950043.","journal-title":"Front Oncol"},{"key":"4544_CR110","doi-asserted-by":"publisher","first-page":"9588","DOI":"10.1080\/21655979.2022.2054206","volume":"13","author":"H Jia","year":"2022","unstructured":"Jia H, Sun W, Li X, Xu W. Melatonin promotes apoptosis of thyroid cancer cells via regulating the signaling of microRNA-21 (miR-21) and microRNA-30e (miR-30e). Bioengineered. 2022;13:9588\u2013601.","journal-title":"Bioengineered"},{"key":"4544_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/dj7020048","author":"M Hunsaker","year":"2019","unstructured":"Hunsaker M, Barba G, Kingsley K, Howard KM. Differential microRNA expression of miR-21 and miR-155 within oral cancer extracellular vesicles in response to melatonin. Dent J. 2019. https:\/\/doi.org\/10.3390\/dj7020048.","journal-title":"Dent J"},{"key":"4544_CR112","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040517","volume":"103","author":"FS Alshehri","year":"2024","unstructured":"Alshehri FS, Althobaiti YS. A review of the potential use of melatonin in cancer treatment: data analysis from Clinicaltrials.gov. Medicine (Baltimore). 2024;103:e40517.","journal-title":"Medicine (Baltimore)"},{"key":"4544_CR113","doi-asserted-by":"publisher","first-page":"46768","DOI":"10.18632\/oncotarget.8776","volume":"7","author":"Z Ma","year":"2016","unstructured":"Ma Z, Yang Y, Fan C, Han J, Wang D, Di S, et al. Melatonin as a potential anticarcinogen for non-small-cell lung cancer. Oncotarget. 2016;7:46768\u201384.","journal-title":"Oncotarget"},{"key":"4544_CR114","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00228-015-1873-4","volume":"71","author":"NG Harps\u00f8e","year":"2015","unstructured":"Harps\u00f8e NG, Andersen LPH, G\u00f6genur I, Rosenberg J. Clinical pharmacokinetics of melatonin: a systematic review. Eur J Clin Pharmacol. 2015;71:901\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"4544_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40360-016-0052-2","volume":"17","author":"LP Andersen","year":"2016","unstructured":"Andersen LP, Werner MU, Rosenkilde MM, Harps\u00f8e NG, Fuglsang H, Rosenberg J, et al. Pharmacokinetics of oral and intravenous melatonin in healthy volunteers. BMC Pharmacol Toxicol. 2016;17:1\u20135.","journal-title":"BMC Pharmacol Toxicol"},{"key":"4544_CR116","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40261-015-0368-5","volume":"36","author":"LPH Andersen","year":"2016","unstructured":"Andersen LPH, G\u00f6genur I, Rosenberg J, Reiter RJ. The safety of melatonin in humans. Clin Drug Investig. 2016;36:169\u201375.","journal-title":"Clin Drug Investig"},{"key":"4544_CR117","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12782","volume":"72","author":"Z Menczel Schrire","year":"2022","unstructured":"Menczel Schrire Z, Phillips CL, Chapman JL, Duffy SL, Wong G, D\u2019Rozario AL, et al. Safety of higher doses of melatonin in adults: a systematic review and meta\u2010analysis. J Pineal Res. 2022;72:e12782.","journal-title":"J Pineal Res"},{"key":"4544_CR118","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1111\/jcmm.15221","volume":"24","author":"N Li","year":"2020","unstructured":"Li N, Wang Z, Gao F, Lei Y, Li Z. Melatonin ameliorates renal fibroblast-myofibroblast transdifferentiation and renal fibrosis through miR-21-5p regulation. J Cell Mol Med. 2020;24:5615\u201328.","journal-title":"J Cell Mol Med"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04544-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04544-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04544-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T07:01:59Z","timestamp":1787468519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04544-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":118,"alternative-id":["4544"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04544-w","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}